Host cell proteins in biotechnology-derived products: A risk assessment framework.

about

Quantitative analysis of the supernatant from host and transfected CHO cells using iTRAQ 8-plex technique.A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies.

P2860

Q38393747-1ECFB9A6-DB4F-4ABE-ABAF-B9F52CDFCDEE Q51174238-A224DA22-E109-48EC-8130-3139FE252A23

P2860

Host cell proteins in biotechnology-derived products: A risk assessment framework.

Item

http://www.wikidata.org/entity/Q43618464

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@en

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@nl

type

Item

label

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@en

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@nl

prefLabel

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@en

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@nl

P1476

Host cell proteins in biotechnology-derived products: A risk assessment framework.

@en

P2093

Christina L Zuch de Zafra

http://www.w3.org/2001/XMLSchema#string

Judith Zhu-Shimoni

http://www.w3.org/2001/XMLSchema#string

Kathleen Francissen

http://www.w3.org/2001/XMLSchema#string

Martin Vanderlaan

http://www.w3.org/2001/XMLSchema#string

Valerie Quarmby

http://www.w3.org/2001/XMLSchema#string

P2860

Children's health and the environment: public health issues and challenges for risk assessment

Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing

Pediatric influenza vaccination: understanding the T-cell response.

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

Host cell protein dynamics in the supernatant of a mAb producing CHO cell line.

Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose-response modeling procedures.

Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.

How to predict and prevent the immunogenicity of therapeutic proteins.

Paediatric anaphylaxis: a 5 year retrospective review.

Use of toll-like receptor assays to detect and identify microbial contaminants in biological products.

P304

2284-2291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIT.25647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26010760

http://www.w3.org/2001/XMLSchema#string

P921

biotechnology

Host cell proteins in biotechnology-derived products: A risk assessment framework.

about

P2860

P2860

Host cell proteins in biotechnology-derived products: A risk assessment framework.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921